Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
For much of the past decade, investing in Europe has been a challenge, which prompts a difficult question: How does one invest in Europe without sinking money in a market that has historically lagged the U.S.? Brian Manby seeks to provide an answer to this question.
It has been a while since European stocks were met with optimism. With recent developments in European fiscal policy, momentum is starting to build. Joe Tenaglia makes the case that European equities could offer a great buying opportunity for investors.
There is a popular belief that the failure of European markets to keep pace with the U.S. over the past decade is caused by overweight positions to banks, which have struggled in the post-crisis environment, and the absence of firms comparable to the U.S. tech giants. Jeremy Schwartz examines this narrative and offers different strategies to include European equities in your portfolio.
Lately it has seemed easy to find reasons to avoid investing in European assets. Christopher Gannatti highlights three reasons why we believe the risks can create valuation opportunities in Europe.
An interesting aspect of the WisdomTree annual rebalance process is identifying trends in aggregate regional Dividend Stream of major markets. As we just rebalanced our developed world Indexes, including Europe, we wanted to provide some insight into how Europe’s dividends grew in the 12 months prior to the rebalance.
Recently, European markets have performed strongly, with many investors focusing on the economic recovery. It is becoming difficult to remember that a few short years ago there was widespread debate about whether the European Monetary Union (EMU) would continue to exist.